Green Cross Health Ltd · NZX:GXH

Green Cross Health — H1 FY2024 Earnings Presentation

20 slides from Green Cross Health's earnings presentation, Nov 29, 2023

  1. Slide 1: Half Year Results Presentation

    GREEN CROSS HEALTH Half Year Results Presentation Unichem? Life-© @pinrop GREEN - thedoctors House HEALTH

  2. Slide 2: Disclaimer

    Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability

  3. Slide 3: Operational Highlights

    Operational Highlights Group • $2.2m increase in Group Revenue year-on-year • Significant investment in IT infrastructure; ERP Highlights upgrade completed and product information system replaced Pharmacy • Total prescriptions up 3.3% on same-store basis • $5 co-payment removal Division • 295,961 fl

  4. Slide 4: GXH Interim Result - Financial Overview

    GXH Interim Result - Financial Overview Group Performance Divisional Performance Group Revenue Pharmacy Operating Profit (EBIT) $250.2m $8.7m 1% increase vs 1H23 25% decrease vs 1H23 Operating Profit (EBIT) Medical Operating Profit (EBIT) $14.9m $7.3m 17% decrease vs 1H23 21% decrease vs 1H23 Net Pr

  5. Slide 5: Pharmacy Division

    Pharmacy Division New Zealand’s largest network of health retailers: supporting easy access to quality health care

  6. Slide 6: Pharmacy Performance

    Pharmacy Performance Pharmacy Revenue ($m) 180 182 • Revenue of $182m 170 • Operating Profit (EBIT) at $8.7m 154 • Diminished levels of higher-margin COVID-19 activity and increased 1H21 1H22 1H23 1H24 labour costs resulted in Operating Profit (EBIT) down 25% Pharmacy Operating Profit/EBIT ($m) • Sa

  7. Slide 7: Operational Highlights - Pharmacy

    Operational Highlights - Pharmacy Flu Vaccines and Total Scripts 350 20 Continued growth in influenza vaccination volumes, up 3.3% on 1H23 300 19 Initial scripts up 5.9% vs. 1H23 for same 18 250 stores Total Network Scripts (m) 17 Flu Vaccines (000's) Increase in loyalty membership to 1.99m 200 175

  8. Slide 8: Pharmacy Will Win By Focusing on the Customer

    Pharmacy Will Win By Focusing on the Customer Workforce productivity Differentiated brand and & occupancy cost products, recognising control Brand & customer loyalty Cost focus customer Leveraging our trusted Professional instore brands, advocating for equity Network scale & Retail experience, margi

  9. Slide 9: Medical Division

    Medical Division Growth, leadership and sustainable models of care

  10. Slide 10: Medical Performance

    Medical Performance Medical Revenue ($m) 68 69 Revenue up 1% to $69m 46 Diminished levels of COVID-19 41 activity and increased labour costs resulted in Operating Profit (EBIT) down 21% to $7.3m 1H21 1H22 1H23 1H24 Review of cost base to minimise Medical Operating Profit/EBIT ($m) impact of labour s

  11. Slide 11: Operational Highlights - Medical

    Operational Highlights - Medical The Doctors App Successful completion of three 25 35 acquisitions to end period with 63 30 Registered Users (‘000) 20 25 Medical Centres medical centres. Two further acquisitions 15 20 completed post Sep-23 10 15 Strong pipeline of future acquisitions 10 5 5 HouseCal

  12. Slide 12: Medical Strategy of Organic Growth & Acquisitions

    Medical Strategy of Organic Growth & Acquisitions Workforce productivity High quality patient care & margin management Cost & margin Patient & focus Brand Continuous improvement Targeted centre focus, clinical development acquisitions Operational Scale improvement Technology Utilising data and syste

  13. Slide 13: Group Financial Result

    Group Financial Result 6 months ending 30 September 2023 GXH Half Year Results Presentation 29 November 2023 Pg 13

  14. Slide 14: Group Revenue and Operating Profit (EBIT)

    Group Revenue and Operating Profit (EBIT) Revenue From Continuing Operations ($m) Operating Profit (EBIT) From Continuing Operations ($m) 17.8 18.1 16.1 14.9 248 250 216 195 1H21 1H22 1H23 1H24 1H21 1H22 1H23 1H24 • Revenue of $250m, up 1% vs 1H23 Operating Profit (EBIT) from continuing • Fourth con

  15. Slide 15: Group NPAT, EPS & Dividend

    Group NPAT, EPS & Dividend Net Profit After Tax Attributable to Shareholders From Continuing Operations ($m) • Net Profit After Tax Attributable to Shareholders down 21% on a continuing 7.7 7.8 operations basis 7.1 5.6 • EPS at 3.91 cps, a decrease of 1 cent • Interim dividend of 2.5 cps ($3.6m) dec

  16. Slide 16: Working Capital and Operating Cash Flow

    Working Capital and Operating Cash Flow Gearing Ratio (debt / debt + equity) GXH Operating Cash Flow ($m) 39.1 22.1% 28.9 16.2% 14.3% 12.4% 17.8 18.8 1H21 1H22 1H23 1H24 1H21 1H22 1H23 1H24 • Gearing ratio of 16.2% as at 30 September 2023 • Operating Cash Flow of $18.8m • Robust working capital mana

  17. Slide 17: Outlook

    Outlook ➢ Challenging retail environment, labour cost pressures and funding shortfalls continue in short-term ➢ Maximising labour efficiency and management of costs a priority ➢ Focus remains on sustained earnings growth through acquisition and investment in new product and service offerings ➢ Earni

  18. Slide 18: About Green Cross Health

    About Green Cross Health GXH Half Year Results Presentation 29 November 2023 Pg 18

  19. Slide 19: Our Purpose

    Our Purpose Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Half Year Results Presentation 29 November 2023 Pg 19

  20. Slide 20: Who We Are

    Who We Are GXH Half Year Results Presentation 29 November 2023 Pg 20

Green Cross Health — H1 FY2024 Earnings Presentation on 6ix